Opus Genetics, Inc. (NASDAQ: IRD) reported Q1 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $4.37 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.